Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjia Yang

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Cardiovascular Diabetology|April 29, 2021
SGLT2 inhibitors and lower limb complications: an updated meta-analysisChu Lin, Xingyun Zhu, Xiaoling Cai, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion|July 16, 2025
[<i>Daoqi</i> acupuncture technique in <i>Huangdi Neijing</i> for moderate-to-severe obstructive sleep apnea-hypopnea syndrome: a randomized controlled trial]Guoqing Zhu, Na Zhao, Lin Tang, et al.
Inflammopharmacology|March 19, 2025
The association between anti-inflammatory therapies and renal outcomes in patients with established cardiovascular disease or high cardiovascular risks: a meta-analysis of randomised controlled trialsWenfeng Yang, Zonglin Li, Chu Lin, et al.
Pesticide Biochemistry and Physiology|December 1, 2025
Recombinant defense protease inhibitors from Vigna unguiculata show bioactivity against non-host related pestsJia Liu, XinYue Tang, KeQian Long, et al.
Bone|November 4, 2019
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysisFang Lv, Xiaoling Cai, Wenjia Yang, et al.
Journal of Medical Economics|January 22, 2019
Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetesXiaoling Cai, Lizheng Shi, Wenjia Yang, et al.
Eclinicalmedicine|March 3, 2023
Trends in baseline HbA1c and body-mass index in randomised placebo-controlled trials of type 2 diabetes from 1987 to 2022: a systematic review and meta-analysisSuiyuan Hu, Chu Lin, Xiaoling Cai, et al.
Frontiers in Pharmacology|July 15, 2026
Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidenceChengwen Li, Chu Lin, Zonglin Li, et al.
Frontiers in Pharmacology|December 9, 2022
Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trialsSuiyuan Hu, Chu Lin, Xiaoling Cai, et al.
Medicine|September 20, 2022
Reduction of C-reactive protein, low-density lipoprotein cholesterol, and its relationship with cardiovascular events of different lipid-lowering therapies: A systematic review and meta-analysis of randomized controlled trialsWenjia Yang, Xiaoling Cai, Chu Lin, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Cardiovascular Diabetology|April 29, 2021
SGLT2 inhibitors and lower limb complications: an updated meta-analysisChu Lin, Xingyun Zhu, Xiaoling Cai, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion|July 16, 2025
[<i>Daoqi</i> acupuncture technique in <i>Huangdi Neijing</i> for moderate-to-severe obstructive sleep apnea-hypopnea syndrome: a randomized controlled trial]Guoqing Zhu, Na Zhao, Lin Tang, et al.
Inflammopharmacology|March 19, 2025
The association between anti-inflammatory therapies and renal outcomes in patients with established cardiovascular disease or high cardiovascular risks: a meta-analysis of randomised controlled trialsWenfeng Yang, Zonglin Li, Chu Lin, et al.
Pesticide Biochemistry and Physiology|December 1, 2025
Recombinant defense protease inhibitors from Vigna unguiculata show bioactivity against non-host related pestsJia Liu, XinYue Tang, KeQian Long, et al.
Bone|November 4, 2019
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysisFang Lv, Xiaoling Cai, Wenjia Yang, et al.
Journal of Medical Economics|January 22, 2019
Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetesXiaoling Cai, Lizheng Shi, Wenjia Yang, et al.
Eclinicalmedicine|March 3, 2023
Trends in baseline HbA1c and body-mass index in randomised placebo-controlled trials of type 2 diabetes from 1987 to 2022: a systematic review and meta-analysisSuiyuan Hu, Chu Lin, Xiaoling Cai, et al.
Frontiers in Pharmacology|July 15, 2026
Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidenceChengwen Li, Chu Lin, Zonglin Li, et al.
Frontiers in Pharmacology|December 9, 2022
Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trialsSuiyuan Hu, Chu Lin, Xiaoling Cai, et al.
Medicine|September 20, 2022
Reduction of C-reactive protein, low-density lipoprotein cholesterol, and its relationship with cardiovascular events of different lipid-lowering therapies: A systematic review and meta-analysis of randomized controlled trialsWenjia Yang, Xiaoling Cai, Chu Lin, et al.
Pageof 15